C4B Gene

📖 Wiki Page

gene1977 wordssynced 2026-04-02

C4B Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">C4B Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>C4B</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Complement Component 4B (Chido/Rodgers Blood Group)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>6p21.3 (MHC Class III)</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>713</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>120820</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000244731</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P0C0S0</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Complement system serine protease</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Systemic Lupus Erythematosus, Autism Spectrum Disorder, Multiple Sclerosis</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>High (increases with activation)</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Neurons</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Endothelial cells</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">C1q</td>
<td>Complex formation</td>
</tr>
<tr>
<td class="label">C1r</td>
<t

...

C4B Gene

Introduction

The C4B gene (Complement Component 4B) encodes a crucial protein in the complement cascade, sharing significant sequence similarity with its close relative C4A while exhibiting distinct biochemical properties and disease associations. Located in the major histocompatibility complex (MHC) class III region on chromosome 6p21.3, C4B is essential for immune defense, inflammation regulation, and increasingly recognized for its role in neurobiology and neurodegenerative diseases[@sekar2016][@wu2019]. Unlike C4A, which preferentially binds amino groups, C4B shows higher affinity for hydroxyl groups on target surfaces, leading to different functional outcomes in complement activation and immune complex handling. Research has revealed important roles for C4B in Alzheimer's disease susceptibility, autoimmune conditions, and neurodevelopmental processes, making it a significant gene for understanding immune-brain interactions in disease.

Gene Overview

Protein Structure and Function

Protein Architecture

C4B encodes complement component 4B, a 1741-amino acid zymogen structurally similar to C4A. The protein is composed of three polypeptide chains:

α-chain (104 kDa): Contains the thioester bond critical for covalent attachment to surfaces. The thioester in C4B preferentially reacts with hydroxyl groups, unlike C4A which prefers amino groups
β-chain (75 kDa): Provides structural stability in circulation
γ-chain (28 kDa): C-terminal fragment generated upon activation

The structural similarity between C4A and C4B (approximately 99% sequence identity in the coding region) reflects their shared evolutionary origin and overlapping functions, yet their distinct thioester reactivity determines their unique roles in immune surveillance and disease pathogenesis.

Biochemical Properties

The key difference between C4A and C4B lies in their thioester chemistry:

C4B reactivity: Preferentially binds hydroxyl groups (sugars, carbohydrates) on microbial surfaces

C4A reactivity: Preferentially binds amino groups (proteins) on immune complexes

Functional implications: C4B is more effective at opsonizing bacteria and foreign particles, while C4A is more efficient at clearing immune complexes

This biochemical distinction has important implications for understanding their differential disease associations.

Complement Pathway Functions

C4B participates in multiple complement activation pathways:

Classical pathway: Activated by C1 complex (C1q:C1r:C1s) binding to antibodies or pathogen surfaces

Lectin pathway: Activated by mannose-binding lectin (MBL) and ficolins

Terminal pathway: C4b contributes to C5 convertase formation and membrane attack complex (MAC) assembly

Cleavage products include:

C4a: Anaphylatoxin that triggers inflammation, histamine release, and immune cell recruitment
C4b: Opsonin that covalently attaches to pathogen surfaces, facilitating phagocytosis

Role in Neurodegeneration

Alzheimer's Disease

C4B has been increasingly implicated in Alzheimer's disease pathogenesis through several mechanisms:

Complement Activation in AD Brain

Elevated C4B expression has been documented in AD brains, particularly in regions affected by amyloid pathology[@zhou2020]. Studies using proteomic analysis of AD brain tissue have identified significant upregulation of complement components, including C4B, in the prefrontal cortex and hippocampus of AD patients compared to age-matched controls[@johnson2019].

Key mechanisms include:

Amyloid plaque opsonization: C4b can bind to amyloid-beta (Aβ) plaques, marking them for microglial clearance
Chronic inflammation: C4B contributes to the neuroinflammatory environment that drives disease progression
Synaptic elimination: C4B-mediated complement activation tags synapses for microglial phagocytosis

Genetic Associations

Genetic studies have identified associations between C4B variants and AD risk:

C4B deficiency: Some studies suggest C4B deficiency is associated with increased AD risk[@lintvedt2013]
Copy number variation: C4B CNV has been linked to disease susceptibility
Haplotype effects: Specific C4B haplotypes show differential association with AD

The relationship between C4B and AD appears to be complex, with both protective and risk-associated variants identified in different populations.

Microglial Activation

C4B serves as a critical signal for microglial activation in the AD brain[@gomez2020]:

C4b acts as a "find me" signal, attracting microglia to sites of pathology
Microglial complement receptors (CR3) recognize C4b-coated targets
This interaction promotes phagocytosis while also driving inflammatory cytokine release

Parkinson's Disease

In Parkinson's disease, C4B contributes to:

Dopaminergic neuron vulnerability: Inflammatory signaling exacerbates loss of neurons in the substantia nigra

Microglial activation: Sustained C4B-mediated complement activation in PD brains

α-synuclein pathology: C4B may interact with α-synuclein aggregates, potentially accelerating pathological spread

Post-mortem studies show increased C4B expression in the substantia nigra of PD patients, correlating with disease severity[@hawkes2023].

Autism Spectrum Disorder

C4B copy number variation has been studied in autism spectrum disorder (ASD):

Copy number association: Some studies link C4B copy number to ASD risk
Synaptic pruning: Altered C4B activity during neurodevelopment may affect synaptic pruning
Immune dysregulation: Complement abnormalities may contribute to immune-related mechanisms in ASD

The relationship between C4B and ASD involves complex gene-environment interactions during critical periods of brain development.

Multiple Sclerosis

C4A and C4B show opposing roles in multiple sclerosis[@vanluijn2015]:

C4B appears pathogenic: Higher C4B expression is associated with disease progression
C4A appears protective: Higher C4A may be beneficial
Mechanism: Differential roles in demyelination and remyelination processes

This dichotomy provides valuable insights into complement-mediated neuroinflammation and suggests that targeting specific complement components may have therapeutic value.

Autoimmune Disease Associations

Systemic Lupus Erythematosus (SLE)

C4B, like C4A, is strongly associated with systemic lupus erythematosus:

C4B Deficiency

Genetic deficiency: Complete C4B deficiency (homozygous null alleles) is a significant genetic risk factor for SLE
Immune complex clearance: C4B deficiency impairs clearance of apoptotic cells and immune complexes
Autoantibody formation: Reduced complement activity leads to accumulation of self-antigens

Phenotypic Differences

C4A vs C4B deficiency may present with different clinical features
C4B deficiency often associated with different autoantibody patterns
Some SLE patients have isolated C4B deficiency without C4A deficiency

Disease Mechanisms

The complement system is essential for:

Clearance of apoptotic cell debris
Processing and clearance of immune complexes
Prevention of autoantibody formation against self-antigens

Other Autoimmune Conditions

C4B variants have been associated with:

Rheumatoid arthritis: Altered complement activation
Type 1 diabetes: Complement-mediated β-cell destruction
Sjögren's syndrome: Immune complex deposition

Expression Pattern

Brain Expression

C4B is expressed in multiple cell types within the central nervous system:

Peripheral Expression

C4B is highly expressed in:

Liver: Primary site of complement protein synthesis (hepatocytes)
Spleen: Immune cell production
Kidney: Local complement production
Lung: Mucosal immune defense

Plasma Levels

C4B contributes to total plasma C4 levels:

Normal range: 0.2-0.5 g/L (combined C4)
Elevated in inflammation
Decreased in complement deficiency states

Genetic Variation

Copy Number Variation

The C4B gene shows extensive copy number variation:

1-6 copies per diploid genome
Higher copy numbers generally correlate with higher expression
CNV associated with schizophrenia, AD, and autoimmune disease risk

Single Nucleotide Polymorphisms

Key SNPs in the C4B region:

Functional variants: Affect thioester reactivity and binding preferences
Regulatory variants: Influence expression levels
Disease-associated variants: Linked to AD, SLE, and MS risk

Gene Structure

The C4B gene spans approximately 21 kb and contains:

41 exons
Alternative splicing variants
MHC class III regulatory elements

Protein Interactions

Therapeutic Implications

Complement Inhibition

Targeting C4B-mediated pathways represents a therapeutic strategy for:

Neurodegenerative diseases: Modulating neuroinflammation

Autoimmune conditions: Reducing pathogenic complement activation

Transplantation: Preventing complement-mediated tissue damage

Challenges

Immune defense: Complement inhibition increases infection risk
Specificity: Targeting C4B specifically while preserving C4A function
Timing: Early intervention may be critical for efficacy

Current Research

Clinical trials are evaluating complement inhibitors for:

Alzheimer's disease
Multiple sclerosis
Systemic lupus erythematosus

Research Methods

Experimental Approaches

Genetic studies: GWAS, exome sequencing, CNV analysis
Proteomics: Quantification of C4B in brain tissue and CSF
Functional studies: In vitro complement activation assays
Animal models: C4B knockout and transgenic mice

Biomarkers

C4B levels may serve as:

Disease progression marker
Treatment response indicator
Prognostic biomarker in neurodegenerative diseases

Key Publications

[Sekar A, et al. Schizophrenia risk from complex variation of complement component 4 (2016)](https://doi.org/10.1038/nature16549)

[van Luijn MM, et al. Opposing roles of C4A and C4B in multiple sclerosis (2015)](https://doi.org/10.1038/nrneurol.2015.216)

[Mayilyan KR, et al. Complement C4 in schizophrenia (2008)](https://doi.org/10.2174/138161208783877652)

[Wu T, et al. C4 in brain: implications for synaptic remodeling (2019)](https://doi.org/10.1007/s11064-019-02852-w)

[Zhou J, et al. Complement component 4 is increased in AD brains (2020)](https://doi.org/10.1007/s12035-020-02013-1)

[Lintvedt M, et al. C4B deficiency and AD risk (2013)](https://doi.org/10.3233/JAD-121714)

[Johnson EC, et al. Proteomic analysis of AD brain complement pathway (2019)](https://pubmed.ncbi.nlm.nih.gov/31847895/)

[Hawkes CA, McLaurin J. Complement activation in AD (2023)](https://pubmed.ncbi.nlm.nih.gov/37612438/)

[Barkley LR, et al. C4B and autoimmune diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35065891/)

[Danielsen MS, et al. C4 and neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35654578/)

Pathway Diagram

Mermaid diagram (expand to render)

External Links

[NCBI Gene: C4B](https://www.ncbi.nlm.nih.gov/gene/713)
[UniProt: P0C0S0](https://www.uniprot.org/uniprot/P0C0S0)
[OMIM: 120820](https://www.omim.org/entry/120820)
[Ensembl: ENSG00000244731](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000244731)
[GWAS Catalog: C4B variants](https://www.ebi.ac.uk/gwas/)
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/)
[Allen Brain Atlas: C4B expression](https://human.brain-map.org/)

Last updated: 2026-03-26

References

barkley2022, Complement component C4B and susceptibility to autoimmune diseases (2022)
chen2021, C4B copy number variation and brain disorders: genetic and functional implications (2021)
danielsen2022, Association between complement component C4 and neurodegenerative diseases (2022)
gomez2020, Microglial dynamics in Alzheimer's disease (2020)
hawkes2023, Complement activation in Alzheimer's disease: therapeutic targeting (2023)
johnson2019, Large-scale proteomic analysis of Alzheimer's disease brain identifies altered complement pathway (2019)
lawrence2020, Complement C4 isoforms and neurodevelopment: implications for brain disorders (2020)
lintvedt2013, C4B deficiency is associated with increased risk of Alzheimer's disease (2013) [1](https://doi.org/10.3233/JAD-121714)
mayilyan2008, Complement C4 in schizophrenia - a focus on the gene (2008) [1](https://doi.org/10.2174/138161208783877652)
morris2018, The role of complement in synaptic pruning and neurodegeneration (2018)
presuthey2022, Complement system in neuropsychiatric disorders (2022)
sarlus2022, Microglia in Alzheimer's disease (2022)
sekar2016, Schizophrenia risk from complex variation of complement component 4 (2016) [1](https://doi.org/10.1038/nature16549)
shi2020, Complement C3 and synaptic homeostasis in aging brain (2020)
sims2017, Rare coding variants in PLD3 reduce risk of Alzheimer's disease (2017)
steckham2019, The emerging role of complement in neurodegeneration (2019)
vanluijn2015, Opposing roles of C4A and C4B in multiple sclerosis (2015) [1](https://doi.org/10.1038/nrneurol.2015.216)
wong2019, Complement-mediated synaptic clearance in health and disease (2019)
wu2019, C4 in brain: implications for understanding synaptic remodeling and schizophrenia (2019) [1](https://doi.org/10.1007/s11064-019-02852-w)
zhou2020, Complement component 4 is increased in Alzheimer's disease brains (2020) [1](https://doi.org/10.1007/s12035-020-02013-1)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[Age-Dependent Complement C4b Upregulation Drives Synaptic Vulnerability in Hippocampal CA1 Neurons](/hypothesis/h-2f43b42f) — <span style="color:#81c784;font-weight:600">0.70</span> · Target: C4B

Pathway Diagram

The following diagram shows the key molecular relationships involving C4B Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

C4B Gene

C4B Gene

Introduction

C4B Gene

Introduction

Gene Overview

Protein Structure and Function

Protein Architecture

Biochemical Properties

Complement Pathway Functions

Role in Neurodegeneration

Alzheimer's Disease

Complement Activation in AD Brain

Genetic Associations

Microglial Activation

Parkinson's Disease

Autism Spectrum Disorder

Multiple Sclerosis

Autoimmune Disease Associations

Systemic Lupus Erythematosus (SLE)

C4B Deficiency

Phenotypic Differences

Disease Mechanisms

Other Autoimmune Conditions

Expression Pattern

Brain Expression

Peripheral Expression

Plasma Levels

Genetic Variation

Copy Number Variation

Single Nucleotide Polymorphisms

Gene Structure

Protein Interactions

Therapeutic Implications

Complement Inhibition

Challenges

Current Research

Research Methods

Experimental Approaches

Biomarkers

Key Publications

Pathway Diagram

See Also

External Links

References

Related Hypotheses

Pathway Diagram